Results 161 to 170 of about 1,568,965 (311)

Workplace violence in a conflict zone: a study from Syria's healthcare frontline. [PDF]

BMC Public Health
Al-Bitar A, Nasra AB, Alsaoub L, Dayoub A, Hmidan A, Barghouth R, Kheder M, Koja H, Abubakir M, Massoud R, Latifeh Y, Alsaid B.   +11 more
europepmc   +1 more source

Reporting potential conflicts of interest

Brazilian Journal of Anesthesiology (English Edition), 2016
openaire   +4 more sources

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Trend, application, and reporting of Mini-health technology assessment: an evidence mapping. [PDF]

Int J Technol Assess Health Care
Wang Z, Li Y, Xu M, Liu W, Yan Y, Wang Y, Wu Y, Li M, Li X, Zhang X.   +9 more
europepmc   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Letter to editor: Intradiscal steroid injection for lumbar canal stenosis: novel but not yet ready for clinical adoption. [PDF]

Asian Spine J
Khurana G, Singla V, Ghai B.
europepmc   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Exploring the youth perceptions of factors contributing to victims' silence during the armed conflict in Ethiopia. [PDF]

Confl Health
Erega BB, Ferede WY, Mitku AK, Belachew TW, Addisu D, Mekuriaw BY, Goshu YA, Alemayehu HD, Lake ES, Arage RB.   +9 more
europepmc   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Measuring conflict related mortality in ten countries of the WHO Eastern Mediterranean Region (2004-2024): A scoping review. [PDF]

PLOS Glob Public Health
Mahgoub EAA, Ferrario A.
europepmc   +1 more source